Conferences - Results from #1220

Viewing 1221-1240 of 11745 articles

ASTRO 2023: Modern Systemic Therapy for Advanced Prostate Cancer

ASTRO 2023: FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide

ASTRO 2023: Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy Vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)

ASTRO 2023: Post-Operative Therapy for Pathologic Node Positive Prostate Cancer

ASTRO 2023: Optimizing Multimodality Therapy for Clinically Node Positive Prostate Cancer

ASTRO 2023: 5-Year Outcomes from PACE B: An International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy vs Conventionally Fractionated or Moderately HypoFractionated External Beam Radiotherapy for Localized Prostate Cancer

ASTRO 2023: Definition of Oligometastatic Disease in the PSMA PET Era and Treatment Approach

ASTRO 2023: Cases in Oligometastatic Prostate Cancer: Partnering for Patient-Centered Care

ASTRO 2023: Treating Oligometastases in Prostate Cancer: Preserving Quality of Life in a “Chronic Disease”

ASTRO 2023: SBRT for Prostate Cancer: Before and After PACE-B

ASTRO 2023: PSMA-Positive Extracellular Vesicles Predict Disease Recurrence in Oligometastatic Castration-Sensitive Prostate Cancer Treated with Stereotactic Ablative Radiotherapy: Analysis of the ORIOLE trial

ASTRO 2023: Prostate Directed Radiation in the Oligometastatic Setting

ASTRO 2023: Detection Rate of 18F-rhPSMA-7.3 PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels 1 ng/mL: Data from the Phase 3 SPOTLIGHT Study

ASTRO 2023: Cross-Comparison Individual Patient Level Analysis of Three Gene Expression Signatures in Localized Prostate in over 50,000 Men

ASTRO 2023: Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer

ASTRO 2023: Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial

ASTRO 2023: The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study

ASTRO 2023: Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate

ASTRO 2023: Conventional vs. Hypo-Fractionated Radiotherapy for High-Risk Prostate Cancer (PCS5), Randomized, Non-Inferiority, Phase 3 Trial: Post-hoc Analysis of IMRT vs. 3D-CRT Radiation Therapy Associated Toxicity

ASTRO 2023: Quality of Life Results of Addition of ADT and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy: NRG Oncology/RTOG 0534 SPPORT

57
58
59
60
61
62
63
64
65
66